Review



peripheral blood cd14 monocytes pbmc  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC peripheral blood cd14 monocytes pbmc
    Peripheral Blood Cd14 Monocytes Pbmc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/pmc12726827-141-2-10
    Average 99 stars, based on 66 article reviews
    peripheral blood cd14 monocytes pbmc - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Trained Immunity: RoadMap for drug discovery and development
    Article Snippet: Primary , Peripheral Blood CD14+ Monocytes (PBMC) , Human , ATCC Product Code: ATCC-PCS-800–010 , https://www.lgcstandards.com/GB/en/search?text=monocyte%20cell%20lines.



    Similar Products

    99
    ATCC peripheral blood cd14 monocytes pbmc
    Peripheral Blood Cd14 Monocytes Pbmc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/pmc12726827-141-2-10
    Average 99 stars, based on 1 article reviews
    peripheral blood cd14 monocytes pbmc - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    92
    iXCells Biotechnologies human peripheral blood cd14 positive monocytes pbmcs
    Human Peripheral Blood Cd14 Positive Monocytes Pbmcs, supplied by iXCells Biotechnologies, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/Human+Peripheral+Blood+CD14%2B+Monocytes/10__1158_slash_1078___0432__ccr___18___0125-71-0-10
    Average 92 stars, based on 1 article reviews
    human peripheral blood cd14 positive monocytes pbmcs - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    99
    ATCC primary peripheral blood cd14 monocytes pbmc human atcc product code
    Primary Peripheral Blood Cd14 Monocytes Pbmc Human Atcc Product Code, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/10__7554_slash_elife__108465-650-23-30
    Average 99 stars, based on 1 article reviews
    primary peripheral blood cd14 monocytes pbmc human atcc product code - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc human peripheral blood cd14+ monocytes (pbmcs)
    Human Peripheral Blood Cd14+ Monocytes (Pbmcs), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/easysep+human+t+cell+isolation+kit/pmc10169850__42003_2023_4876_MOESM1_ESM-447-0-23
    Average 90 stars, based on 1 article reviews
    human peripheral blood cd14+ monocytes (pbmcs) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza cd14 + peripheral blood-derived monocytes (pbmcs
    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis <t>in</t> <t>CD14</t> + peripheral blood-derived monocytes <t>(PBMCs).</t> (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.
    Cd14 + Peripheral Blood Derived Monocytes (Pbmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/cd14++monocytes/pmc09748617-60-5-10
    Average 90 stars, based on 1 article reviews
    cd14 + peripheral blood-derived monocytes (pbmcs - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza human cd14+ peripheral blood-derived monocytes (pbmcs; lot no. 2050813521)
    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis <t>in</t> <t>CD14</t> + peripheral blood-derived monocytes <t>(PBMCs).</t> (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.
    Human Cd14+ Peripheral Blood Derived Monocytes (Pbmcs; Lot No. 2050813521), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/cd14++monocytes/pm35922474-256-4-12
    Average 90 stars, based on 1 article reviews
    human cd14+ peripheral blood-derived monocytes (pbmcs; lot no. 2050813521) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza human cd14 + peripheral blood-derived monocytes (pbmcs; lot no. 2050813521)
    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis <t>in</t> <t>CD14</t> + peripheral blood-derived monocytes <t>(PBMCs).</t> (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.
    Human Cd14 + Peripheral Blood Derived Monocytes (Pbmcs; Lot No. 2050813521), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/cd14++monocytes/pmc09349189-223-5-13
    Average 90 stars, based on 1 article reviews
    human cd14 + peripheral blood-derived monocytes (pbmcs; lot no. 2050813521) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    pbmcs  (ATCC)
    99
    ATCC pbmcs
    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis <t>in</t> <t>CD14</t> + peripheral blood-derived monocytes <t>(PBMCs).</t> (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.
    Pbmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/Primary+Peripheral+Blood+CD14%2B+Monocytes%2C+Normal%2C+Human/pm34634611-49-16-17
    Average 99 stars, based on 1 article reviews
    pbmcs - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Lonza human cd14 + peripheral blood-derived monocytes (pbmcs)
    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis <t>in</t> <t>CD14</t> + peripheral blood-derived monocytes <t>(PBMCs).</t> (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.
    Human Cd14 + Peripheral Blood Derived Monocytes (Pbmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peripheral+blood+cd14+monocytes+pbmc/cd14++monocytes/pmc07897289-57-5-10
    Average 90 stars, based on 1 article reviews
    human cd14 + peripheral blood-derived monocytes (pbmcs) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis in CD14 + peripheral blood-derived monocytes (PBMCs). (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: miR-1260b inhibits periodontal bone loss by targeting ATF6β mediated regulation of ER stress

    doi: 10.3389/fcell.2022.1061216

    Figure Lengend Snippet: Cell culture supernatant from miR-1260b mimic/ATF6β small interfering RNA (siRNA)-transfected PDL cells inhibits osteoclastogenesis in CD14 + peripheral blood-derived monocytes (PBMCs). (A) Scheme for the validation of the effect of cell culture supernatant from PDL cells on osteoclast differentiation. PDL cells were transfected with either miRNA mimic (miR-Ctrl or miR-1260b) or siRNA (si-Ctrl or si-ATF6β) for 24 h. After changing the medium, cells were stimulated with tunicamycin (0.5 μg/ml) for 24 h. CD14 + PBMCs were stimulated with M-CSF for 3 days, and then incubated with the cell culture supernatant from PDL cells as described above for additional 3 days. PBMCs were further stimulated with the receptor activator of NF-κB ligand (RANKL)/macrophage colony-stimulating factor (M-CSF) for up to 14 days (B) Representative images of tartrate-resistant acid phosphatase (TRAP) staining. Scale bar = 200 μm. (C,D) Osteoclast differentiation was evaluated by the number of TRAP-positive multinucleated cells (MNCs) (7 or 10 ≤ nuclei) (C) and the size of TRAP-positive MNCs (3 ≤ nuclei) (D) . n = 3. (E) Representative images of the resorption pit on the calcium phosphate (CaP)-coated plate. Scale bar = 200 μm. (F) Total resorbed area in each culture was measured. n = 3. * p < 0.05, ** p < 0.01, **** p < 0.0001. The significance of differences between groups was determined using one-way ANOVA, followed by correction for multiple comparisons with Tukey’s post hoc test.

    Article Snippet: Human CD14 + peripheral blood-derived monocytes (PBMCs) were purchased from Lonza (Basel, Switzerland).

    Techniques: Cell Culture, Small Interfering RNA, Transfection, Derivative Assay, Incubation, Staining